Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.

Chen YC, Page JH, Chen R, Giovannucci E.

Prostate. 2008 Oct 1;68(14):1582-91. doi: 10.1002/pros.20825.

PMID:
18646000
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Epidemiological fundamentals of clinically localized prostate cancer].

Martínez-Salamanca JI, Ballesteros CM, Carballido Rodríguez J.

Arch Esp Urol. 2011 Oct;64(8):703-10. Review. Spanish.

PMID:
22052753
[PubMed - indexed for MEDLINE]
3.

New circulating biomarkers for prostate cancer.

Bensalah K, Lotan Y, Karam JA, Shariat SF.

Prostate Cancer Prostatic Dis. 2008;11(2):112-20. Epub 2007 Nov 13. Review.

PMID:
17998918
[PubMed - indexed for MEDLINE]
4.

Genetic epidemiology of prostate cancer.

Narod S.

Biochim Biophys Acta. 1999 Jan 29;1423(1):F1-13. Review.

PMID:
9989206
[PubMed - indexed for MEDLINE]
Free Article
5.

Risk of developing prostate cancer in the future: overview of prognostic biomarkers.

Fleshner NE, Lawrentschuk N.

Urology. 2009 May;73(5 Suppl):S21-7. doi: 10.1016/j.urology.2009.02.022. Review. Erratum in: Urology. 2010 Sep;76(3):771.

PMID:
19375623
[PubMed - indexed for MEDLINE]
6.

[Prostate cancer. Epidemiology. Risk factors. Pathology].

Fournier G, Valeri A, Mangin P, Cussenot O.

Ann Urol (Paris). 2004 Oct;38(5):187-206. Review. French.

PMID:
15570704
[PubMed - indexed for MEDLINE]
7.

Biology of prostate-specific antigen.

Lilja H.

Urology. 2003 Nov;62(5 Suppl 1):27-33. Review.

PMID:
14607215
[PubMed - indexed for MEDLINE]
8.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
[PubMed - indexed for MEDLINE]
9.

Genetic counseling for prostate cancer risk.

Nieder AM, Taneja SS, Zeegers MP, Ostrer H.

Clin Genet. 2003 Mar;63(3):169-76. Review.

PMID:
12694223
[PubMed - indexed for MEDLINE]
10.

The influence of family history on prostate cancer risk: implications for clinical management.

Madersbacher S, Alcaraz A, Emberton M, Hammerer P, Ponholzer A, Schröder FH, Tubaro A.

BJU Int. 2011 Mar;107(5):716-21. doi: 10.1111/j.1464-410X.2010.10024.x. Epub 2010 Dec 16. Review.

PMID:
21166744
[PubMed - indexed for MEDLINE]
11.

The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.

Powell IJ.

Arch Esp Urol. 2011 Oct;64(8):711-9. Review. English, Spanish.

PMID:
22052754
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Constitutional risk factors in prostate cancer].

Ferrís-i-Tortajada J, García-i-Castell J, Berbel-Tornero O, Ortega-García JA.

Actas Urol Esp. 2011 May;35(5):282-8. doi: 10.1016/j.acuro.2010.12.009. Epub 2011 Mar 24. Review. Spanish.

PMID:
21435741
[PubMed - indexed for MEDLINE]
13.

Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts.

Ekman P.

Eur Urol. 1999;35(5-6):362-9. Review.

PMID:
10325490
[PubMed - indexed for MEDLINE]
14.

Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features.

López-Otín C, Diamandis EP.

Endocr Rev. 1998 Aug;19(4):365-96. Review. No abstract available.

PMID:
9715372
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk